GabrielliAAvvedimentoEVKriegT.Mechanisms of disease: Scleroderma. N Engl J M2009;
360: 1989–2003.
2.
Van den HoogenFKhannaDFransenJ, et al.
2013 Classification criteria for systemic sclerosis. An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum2013;
65: 2737–2747.
3.
MeuneCVignauxOKahanA, et al.
Heart involvement in systemic sclerosis: Evolving concept and diagnostic methodologies.Arch Cardiovasc Dis2010;
10346–52.
4.
KomócsiAVorobcsukAFaludiR, et al.
The impact of cardiopulmonary manifestations on the mortality of SSC: A systematic review and meta-analysis of observational studies. Rheumatology (Oxford)2012;
51: 1027–1036.
5.
Stronati G, Manfredi L, Ferrarini A, et al. Subclinical progression of systemic sclerosis-related cardiomyopathy. Eur J Prev Cardiol 2020; 27: 1876–1886
6.
RangarajanVMatiaszRFreedBH.Cardiac complications of systemic sclerosis and management: Recent progress.Curr Opin Rheumatol2017;
29: 574–584.
7.
SpethmannSDregerHSchattkeS, et al.
Two-dimensional speckle tracking of the left ventricle in patients with systemic sclerosis for an early detection of myocardial involvement. Eur Heart J Cardiovasc Imaging2012;
13: 863–870.
8.
GuerraFStronatiGFischiettiC, et al.
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis. Eur J Prev Cardiol2018;
25: 1598–1606.
9.
PapagorasCAchenbachKTsifetakiN, et al.
Heart involvement in systemic sclerosis: A combined echocardiographic and scintigraphic study. Clin Rheumatol2014;
33: 1105–1111.
10.
RossLPriorDProudmanS, et al.
Defining primary systemic sclerosis heart involvement: A scoping literature review. Semin Arthritis Rheum2019;
48: 874–887.